Weekly Digest – September 2025 Weekly Digest – September 2025 3 September 2025: Radiance Biopharma signs exclusive license for ‘first in class’ c-Met/EGFR targeted Nano antibody ADC Radiance Biopharma signed an exclusive license agreement with Novatim Immune Therapeutics for global […]
Weekly Digest – September 2025 Weekly Digest – September 2025 3 September 2025: OBI Pharma and AP Biosciences sign technology collaboration agreement to develop next-generation ADC OBI Pharma entered into a Material Transfer and Technology Development Agreement with AP Biosciences […]
Weekly Digest – September 2025 Weekly Digest – September 2025 02 September 2025: Twist Bioscience collaborates with Synthetic Design Lab Twist Bioscience announced a collaboration with Synthetic Design Lab (SDL) to develop novel antibody-drug conjugates (ADCs) for cancer Twist will […]
